Relapse Prevention by Acamprosate
Archives of General PsychiatryPublished 1 August 1996
Henning Saß
Citations485
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Acamprosate proved to be a safe and effective aid in treating alcohol-dependent patients and in maintaining the abstinence of patients during 2 years.
Abstract
Acamprosate proved to be a safe and effective aid in treating alcohol-dependent patients and in maintaining the abstinence of patients during 2 years.
Keywords
Medicine
Proceedings of the National Academy of SciencesDrugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
4,718 Citations1988G. Di Chiara, Assunta Impérato
Archives of General PsychiatryNaltrexone in the Treatment of Alcohol Dependence
1,856 Citations1992Joseph R. Volpicelli
Naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse, and was seen in patients who drank any alcohol while attending outpatient treatment.
Archives of General PsychiatryNaltrexone and Coping Skills Therapy for Alcohol Dependence
1,503 Citations1992Stephanie S. O’Malley
Naltrexone proved superior to placebo in measures of drinking and alcohol- related problems, including abstention rates, number of drinking days, relapse, and severity of alcohol-related problems.
ScienceEthanol Inhibits NMDA-Activated Ion Current in Hippocampal Neurons
1,460 Citations1989David M. Lovinger, Geoffrey White +1 more
The potency for inhibition of the NMDA-activated current by several alcohols is linearly related to their intoxicating potency, suggesting that alcohol-induced inhibition of responses to NMDA receptor activation may contribute to the neural and cognitive impairments associated with intoxication.
Alcoholism Treatment: Context, Process, and Outcome
537 Citations1990Rudolf H. Moos, John W. Finney +1 more
Evaluating and improving alcoholism treatment programsObjectives, methods, and assessment of treatment implementation Short-term outcome and patient prognosis Gender and marital status in treatment and outcome.
The British Journal of PsychiatryKindling as a Model for Alcohol Withdrawal Syndromes
473 Citations1978James C. Ballenger, Robert M. Post
It is suggested that long-term changes in neuronal excitability might relate to the progression of alcohol withdrawal symptoms from tremor to seizures and delirium tremens, as well as the alcoholic personality changes between episodes of withdrawal.
European Journal of PharmacologyEthanol withdrawal seizures and the NMDA receptor complex
441 Citations1990Kathleen A. Grant, Peter Valverius +2 more
Trends in Pharmacological Sciences5-HT and alcohol abuse
326 Citations1992Edward M. Sellers, Guy A. Higgins +1 more
If the initial research findings with these drugs are confirmed and extended, they may present useful therapies for the treatment of alcohol abuse, especially if used in conjunction with psychosocial therapy.
Alcoholism Clinical and Experimental ResearchRepeated Episodes of Ethanol Withdrawal Potentiate the Severity of Subsequent Withdrawal Seizures: An Animal Model of Alcohol Withdrawal “Kindling”
288 Citations1993Howard C. Becker, Robert L. Hale
The results indicated that the severity of EtOH withdrawal seizures was significantly greater in animals that had a prior history of withdrawal episodes in comparison to a separate group of animals that were tested following a single withdrawal from the same 16-hr intoxication period.
Trends in Pharmacological SciencesNeurobiology of alcohol abuse
268 Citations1992Herman H. Samson, R. Adron Harris
Recent studies have found, contrary to earlier assumptions, that ethanol has selective, dose-dependent effects on various neurotransmitter systems within the CNS, and these effects are observed at all levels of analysis, from molecular to behavioral.
AddictionAcamprosate in alcohol dependence: how does it work?
253 Citations2003John M. Littleton
It is suggested that acamprosate may reduce craving that is associated with conditioned withdrawal and be a novel kind of agent that suppresses "craving" in weaned alcohol dependent patients.
Clinical Pharmacology & TherapeuticsFluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
229 Citations1990Claudio A. Naranjo, K Kadlec +3 more
The findings with men who are problem drinkers indicate that fluoxetine differentially alters consummatory behaviors, and the reductions in alcohol intake and body weight are of clinical importance.
Drug Information JournalThe Application of the Principle of Intention–to–Treat to the Analysis of Clinical Trials
229 Citations1991Dennis B. Gillings, Gary G. Koch
A chronology of populations of patients eligible for analysis in clinical trials is discussed, and sensitivity analyses are proposed to address dilemmas as to which population of patients is appropriate for the final analysis of the trial.
Alcohol and AlcoholismACAMPROSATE APPEARS TO DECREASE ALCOHOL INTAKE IN WEANED ALCOHOLICS
191 Citations1990J.P. Lhuintre, Nicholas M. Moore +9 more
CA proved superior to placebo on the evolution of markers of alcohol ingestion at three months, in this large-scale multicenter study, suggesting it could be a new modality in the drug therapy of alcoholism.
Pharmacology Biochemistry and BehaviorA homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?
183 Citations1984F Boismare, Martine Daoust +5 more
European Journal of PharmacologyAcamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors
176 Citations1993Marc L. Zeise, S Kasparov +2 more
The data suggest that acamprosate reduces the postsynaptic efficacy of excitatory amino acid neurotransmitters and lowers neuronal excitability in the neocortical neurons of the rat.
Neurochemistry InternationalAlcohol and central neurotransmission
97 Citations1988H Ollat, H. Parvez +1 more
Neuronal dysfunctions are the neurobiological basis for the alcohol behaviour, and ethanol craving seems specifically related to hypofunction of the noradrenergic, GABAergic and serotoninergic systems, and maintained by a positive reinforcement mediated by the dopaminergic and opioid systems.
Birkhäuser Basel eBooksThe role of the NMDA receptor in ethanol withdrawal
93 Citations1994Paula L. Hoffman, B Tabakoff
It is demonstrated that there is an adaptive "up-regulation" ofNMDA receptor function in brains of chronically ethanol-treated animals and in cultured cells that have been exposed chronically to ethanol, indicating a key role of the NMDA receptor in the well-characterized neuronal damage that is observed after chronic ethanol exposure and withdrawal in animals and humans.
Serotonergic and Dopaminergic Involvement in Ethanol Intake
89 Citations1992J. Engel, Charlotta Enerbäck +6 more
Pharmacology Biochemistry and BehaviorAcamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats
78 Citations1992Martine Daoust, E. Legrand +5 more
It is concluded that the action of ethanol and acamprosate on GABA transport could be, in part, responsible for the modulation by acamproate treatment of ethanol behaviour.
PubMedProspects for a rational pharmacotherapy of alcoholism.
74 Citations1989Meyer Re
The prospects for a rational pharmacotherapy in the rehabilitation of alcohol-dependent patients are described and some specific areas of research need are highlighted, and some implications for clinical practice are described.
Neuroscience Lettersl-Homocysteic acid but not l-glutamate is an endogenous receptor preferring agonist in rat neocortical neurons in vitro
63 Citations1987Thomas Knöpfel, Marc L. Zeise +2 more
Ionophoretically applied D-2-amino-5-phosphonovalerate (2-APV) at doses sufficient to abolish NMDA responses, markedly reduced the L-HCA induced depolarizations but had no detectable effect on theL-Glu responses.
European Journal of PharmacologyAcamprosate and alcohol: III. Effects on alcohol discrimination in the rat
62 Citations1996Rainer Spanagel, W. Zieglgänsberger +1 more
In conclusion, acamprosate does not generalize for the ethanol cue, suggesting that it is not a substitution drug and does not seem to act via the dizocilpine binding site of the N-methyl-D-aspartic acid (NMDA) channel.
Recent developments in alcoholismBenzodiazepines in the Treatment of Alcoholism
55 Citations1989David Nutt, Bryon Adinoff +1 more
Benzodiazepines are not indicated for the treatment of alcoholism and they have very few indications in alcoholics and their dependency-producing potency has to be appreciated when they are used in patients with alcoholism.
PubMedDiagnosis of alcoholism: the Munich Alcoholism Test (MALT).
52 Citations1979W. Feuerlein, C Ringer +2 more
Calcium-Acetylhomotaurinate for Maintaining Abstinence in Weaned Alcoholic Patients: A Placebo-Controlled Double-Blind Multicenter Study
50 Citations1992Isidore Pelc, Olivier Le Bon +3 more
Drugs used for attenuating alcohol intake consist of two types: agents postulated to attenuate drinking by causing aversive consequences if alcohol is consumed after they are ingested, including disulfiram.
AlcoholLack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats
42 Citations1987J. Le Magnen, Gilles Tran +1 more
It is concluded that the acute activity of Ca-AOTA on CNS mechanisms presumably involved in the state of tolerance-dependence, other than those concerned in ethanol-induced hypothermia, motor impairment and taste aversion, may explain its action on the reinforcing property of ethanol intake.
PubMedPhysicochemical, pharmacological and pharmacokinetic study of a new GABAergic compound, calcium acetylhomotaurinate.
34 Citations1988Christiane Chabenat, Pierre Chrétien +7 more
Ca AOTA is an extremely stable drug, totally dissociated in hydrophilic media, which acts centrally as a GABA agonist after crossing the blood-brain barrier, and presumably crosses barriers with the help of a transporter.
PubMedReview and discussion of statistical analysis of controlled clinical trials in alcoholism.
34 Citations1993P. Lehert
63 controlled clinical trials for drug therapy in alcoholism, published during the period 1970-1991 and investigating the efficacy of four different pharmacological agents are reviewed from the statistical analysis point of view.
Calcium-Diacetyl-Homotaurinate which Pre-Vents Relapse in Weaned Alcoholics Decreases the Action of Excitatory Amino Acids in Neo-Cortical Neurons of the Rat in Vitro
16 Citations1992W. Zieglgänsberger, Marc L. Zeise
There is growing evidence that in addition to biogenic amines, neuropeptides and steroids, amino acids like L-glutamate (L-GLU) and y-amino butyric acid (GABA) are involved in the acute and chronic action of ethanol.
PubMedAssessment of treatment outcome.
13 Citations1991Fuller Rk
A description of the type of patients treated by the program, independent raters, and adequate follow-up of those entering treatment are essential for program evaluation; and the credibility of program evaluation would be enhanced by the use of objective measures of treatment response.
PubMedNoradrenaline and GABA brain receptors are co-involved in the voluntary intake of ethanol by rats.
12 Citations1987Martine Daoust, Lhuintre Jp +4 more
It is suggested that both GABA and noradrenaline are implicated in ethanol intake, and that there is a common final pathway of the two systems to modulate ethanol intake.